Oxidative stress status: possible guideline for clinical management of critically ill patients

被引:0
|
作者
Bela, P [1 ]
Bahl, R [1 ]
Sane, AS [1 ]
Sawant, PH [1 ]
Shah, VR [1 ]
Mishra, VV [1 ]
Trivedi, HL [1 ]
机构
[1] Inst Kidney Dis & Res Ctr, Dept Biochem, Ahmadabad 380016, Gujarat, India
关键词
oxidative stress; critical care; malondialdehyde; superoxide dismutase;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Critical care medicine has developed in the last few years into a separate scientific discipline and studies related to the outcome after intensive care usually suggest a long hospital stay that becomes cost prohibitive. The majority of problems (death) amongst critically ill patients requiring critical care involve sepsis, inflammation, tissue damage-oxidative stress, oxygen tension PO2, lipid peroxidation. The present investigation involves monitoring of serum levels of MDA, SOD as a possible guideline for severity of clinical situations in critically ill patients. Methods. Fifty critically ill heterogeneous patients requiring intensive care in the ICU of IKDRC were selected as subjects with ages varying from 17 to 75 years. Serum levels of MDA (ng/ml), SOD (U/ml) were determined right from admission to discharge due to improvement/DAMA/death. MDA and SOD were estimated according to the methods of Buege and Aust ef al, (1978), Nandi and Chatterji (1988). Results. Critically ill patients irrespective of the disease process indicated significantly very high serum levels of MDA and low levels of SOD at the time of admission (13.28 +/-4.26 ng/ml, 3.80 +/-2.60 U/ml, respectively) according to the severity of the prevalent clinical situation. The pattern of serum levels of MDA and SOD according to subsequent clinical performance did indicate a decreasing trend of MDA (oxidant) and fluctuating trend of SOD (antiozidant enzyme except in those who inevitably succumbed to death in spite of adequate clinical management. Conclusions, The results of the present study have amply revealed the utility and relevance of monitoring oxidative stress in critically ill patients as biochemical markers, cost effectiveness and role in decision making (withdrawal/continuation of different support modalities) as deemed fit.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 50 条
  • [21] Iron Use in Critically Ill Patients: No More Stress?
    Rakonczay, Zoltan, Jr.
    CRITICAL CARE MEDICINE, 2016, 44 (03) : 638 - 639
  • [22] Protocol for the adaptation of clinical practice guidelines for the management of physical restraints in critically ill patients
    Cui, Nianqi
    Zhang, Yuping
    Liu, Yuanfei
    Zhou, Yingfeng
    Sun, Hong
    Jin, Jingfen
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (04) : 4889 - +
  • [23] Investigation and management of hypocalcaemia amongst critically ill patients
    A Carins
    M Mogk
    ID Welters
    Critical Care, 15 (Suppl 1):
  • [24] Pharmacological and Nonpharmacological Management of Delirium in Critically Ill Patients
    Hipp, Dustin M.
    Ely, E. Wesley
    NEUROTHERAPEUTICS, 2012, 9 (01) : 158 - 175
  • [25] Management of candidaemia and invasive candidiasis in critically ill patients
    Chahoud, Jad
    Kanafani, Zeina A.
    Kanj, Souha S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S29 - S35
  • [26] Plasma redox status relates to severity in critically ill patients
    de Vega, JMA
    Díaz, J
    Serrano, E
    Carbonell, LF
    CRITICAL CARE MEDICINE, 2000, 28 (06) : 1812 - 1814
  • [27] Nutritional management in critically ill trauma patients is challenging
    Service, Emma
    Anwar, Fahim
    TRAUMA-ENGLAND, 2016, 18 (03): : 231 - 236
  • [28] The design of randomized clinical trials in critically ill patients
    Hébert, PC
    Cook, DJ
    Wells, G
    Marshall, J
    CHEST, 2002, 121 (04) : 1290 - 1300
  • [29] Vitamin D status in critically ill patients: back to basics!
    Anne-Françoise Rousseau
    Etienne Cavalier
    Critical Care, 18
  • [30] Clinical pharmacokinetic monitoring of midazolam in critically ill patients
    Spina, Sean P.
    Ensom, Mary H. H.
    PHARMACOTHERAPY, 2007, 27 (03): : 389 - 398